Misty Dawn Shields (@drshieldsmd) 's Twitter Profile
Misty Dawn Shields

@drshieldsmd

Translational Thoracic Oncologist, #MDPhD, @TheShieldsLab studying #SCLC, Asst Prof, Indiana University, HHMI Med Into Grad Scholar, IASLC ILCF @SCLCSMASHERS

ID: 1859413411

calendar_today13-09-2013 03:50:44

1,1K Tweet

1,1K Takipçi

1,1K Takip Edilen

Misty Dawn Shields (@drshieldsmd) 's Twitter Profile Photo
Misty Dawn Shields
@drshieldsmd

6 days ago

Dr. Megan Daly presents at #ASCO25 the SWOG Cancer Research Network S1914 Phase 3 study. Unfortunately, SBRT + atezolizumab failed to improve PFS or OS over SBRT in early stage unresectable/inoperable high-risk NSCLC. ⭐️Stopped early for futility ⭐️PFS 1.85, OS 1.76 for SBRT+atezo ⭐️⬆️local POD

Dr. Megan Daly presents at #ASCO25 the <a href="/SWOG/">SWOG Cancer Research Network</a> S1914 Phase 3 study. Unfortunately, SBRT + atezolizumab failed to improve PFS or OS over SBRT in early stage unresectable/inoperable high-risk NSCLC. ⭐️Stopped early for futility ⭐️PFS 1.85, OS 1.76 for SBRT+atezo ⭐️⬆️local POD